Table 6.
Net benefit of the Mayo criteria and nomogram scoring system in predicting metastatic lymph nodes in the training cohort.
| Threshold (%) | Net benefit | Advantage of nomogram | ||
|---|---|---|---|---|
| Mayo(%) | Nomogram(%) | Net benefit (%) | Net reduction (%) | |
| 0 | 8.0 | 8.0 | 0.0 | 0.0 |
| 1 | 7.1 | 7.1 | 0.0 | 0.0 |
| 2 | 6.3 | 6.1 | −0.2 | −9.8 |
| 3 | 5.6 | 5.8 | 0.2 | 6.5 |
| 4 | 5.0 | 5.5 | 0.5 | 12.0 |
| 5 | 4.3 | 5.3 | 1.0 | 19.0 |
| 6 | 3.6 | 5.0 | 1.4 | 21.9 |
| 7 | 2.8 | 4.7 | 1.9 | 25.2 |
| 8 | 2.1 | 4.4 | 2.3 | 26.5 |
| 9 | 1.4 | 4.1 | 2.7 | 27.3 |
| 10 | 0.6 | 3.8 | 3.2 | 28.8 |
| 11 | 0.0 | 3.5 | 3.5 | 28.3 |
| 12 | 0.0 | 3.2 | 3.2 | 23.5 |
| 13 | 0.0 | 2.9 | 2.9 | 19.4 |
| 14 | 0.0 | 2.5 | 2.5 | 15.4 |
| 15 | 0.0 | 2.2 | 2.2 | 12.5 |
| 16 | 0.0 | 1.9 | 1.9 | 10.0 |
| 17 | 0.0 | 1.5 | 1.5 | 7.3 |
| 18 | 0.0 | 1.1 | 1.1 | 5.0 |
| 19 | 0.0 | 0.8 | 0.8 | 3.4 |
| 20 | 0.0 | 0.4 | 0.4 | 1.6 |